摘要
蛋白质经常暴露在环境压力下,如自由基和热休克导致的错误折叠和后聚合。活性氧(ROS)对特定的线粒体蛋白的挑战是由于细胞器的氧化代谢。蛋白质聚集了各种各样的有关病理状态称为proteopathies。然而,对于蛋白质和维持细胞稳态,线粒体还制定了一个详细的蛋白质量控制系统组成的伴侣和ATP依赖的蛋白酶,专门用来拯救这器官免受损害由于积累的错误折叠蛋白的聚集和毒性。老化的特点是线粒体功能的普遍下降,与线粒体蛋白的质量控制活动减少,并增加自由基的产生。特别是在与年龄有关的疾病,如神经退行性疾病,线粒体损伤和疾病的发病之间的相关性已经建立。在这篇综述中,我们总结了目前关于在哺乳动物细胞中线粒体蛋白的质量控制机制的知识,特别强调了在氧化应激和神经退行性疾病的作用。
关键词: 阿尔茨海默病,线粒体蛋白质的质量控制(mtPQC),氧化应激,帕金森病。
Current Alzheimer Research
Title:Role of Mitochondrial Protein Quality Control in Oxidative Stress-induced Neurodegenerative Diseases
Volume: 13 Issue: 2
Author(s): Giovanna Cenini and Wolfgang Voos
Affiliation:
关键词: 阿尔茨海默病,线粒体蛋白质的质量控制(mtPQC),氧化应激,帕金森病。
摘要: Proteins are constantly exposed to environmental stressors such as free radicals and heat shock leading to their misfolding and later to aggregation. In particular mitochondrial proteins are challenged by reactive oxygen species (ROS) due to the oxidative metabolism of the organelle. Protein aggregation has been associated with a wide variety of pathological conditions called proteopathies. However, for the maintenance of protein and cellular homeostasis, mitochondria have developed an elaborate protein quality control system consisting of chaperones and ATP-dependent proteases, specifically employed to rescue this organelle from damage due to the accumulation of misfolded proteins and toxic aggregates. Aging is characterized by a general decline of mitochondrial functions, correlating with a decrease in mitochondrial protein quality control activity and an increase of free radical production. In particular in age-related diseases like neurodegeneration, a correlation between mitochondrial damage and disease onset has been established. In this review we summarize the current knowledge about mitochondrial protein quality control mechanisms in mammalian cells, with a special emphasis on the role in oxidative stress and in neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Giovanna Cenini and Wolfgang Voos , Role of Mitochondrial Protein Quality Control in Oxidative Stress-induced Neurodegenerative Diseases, Current Alzheimer Research 2016; 13 (2) . https://dx.doi.org/10.2174/1567205012666150921103213
DOI https://dx.doi.org/10.2174/1567205012666150921103213 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Hot Topic :Treatment with Antidepressants)
Current Pharmaceutical Design Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology Cerebral Microinfarcts and Dementia: A Systematic Review and Metaanalysis
Current Alzheimer Research Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer’s Disease
Current Alzheimer Research Uleine Disrupts Key Enzymatic and Non-Enzymatic Biomarkers that Leads to Alzheimer’s Disease
Current Alzheimer Research Disease-Modifying Therapies in Frontotemporal Lobar Degeneration
Current Medicinal Chemistry Olfactory Dysfunction and Cognitive Impairment in Age-Related Neurodegeneration: Prevalence Related to Patient Selection, Diagnostic Criteria and Therapeutic Treatment of Aged Clients Receiving Clinical Neurology and Community-Based Care
Current Clinical Pharmacology Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Current Pharmaceutical Design Closure of Patent Foramen Ovale: When and How?
Current Vascular Pharmacology Radiopharmaceuticals in Neurological and Psychiatric Disorders
Current Clinical Pharmacology Validating Immunotherapy in Alzheimer’s Disease: The EB101 Vaccine
Current Pharmaceutical Design Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart
Current Pharmaceutical Design Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis
Current Neurovascular Research Is There Any Scientific Basis of Hawan to be Used in the Alzheimer’s Disease Prevention/Cure?
Current Traditional Medicine The Role of ER Stress-Induced Apoptosis in Neurodegeneration
Current Alzheimer Research Pin1: A New Genetic Link between Alzheimer’s Disease, Cancer and Aging
Current Aging Science Diagnosis in PANDAS: An Update
Current Psychiatry Research and Reviews Acetylcholinesterase Inhibition in Alzheimers Disease
Current Pharmaceutical Design Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry The Molecular Basis of Conantokin Antagonism of NMDA Receptor Function
Current Drug Targets